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study of case, a young patient with dyslipidemia in statin use only,
with reports of chronic fatigue, was selected to receive supplemen-
tation of CoQ10 (100 mg) and Withania somnifera (300 mg dry
extract), in capsules, blindly for 30 days each, in addition to
answering validated questionnaire on fatigue (Piper Fatigue Scale-
Revised [PFSR]), usual dietary recall and perform biochemical tests
after each period. Results: Both supplementation shows improved
their symptoms of fatigue reported (PFSR basal 69,1% versus CoQ10
50,0% and Withania somnifera 43,2%), but there was a change of
biochemical parameters for total cholesterol (185 mg/dL to 313 mg/dL),
high density lipoprotein (HDL) (43 mg/dL to 55 mg/dL), LDL (124 mg/dL
to 226 mg/dL) and triglycerides (91 to 159 mg/dL) after use ofWithania
somnifera, in comparison with CoQ10, without alter in your habitual
dietary. Conclusion: Therefore, the use of herbal medicine can be a viable
alternative and effective supplementation in patients reporting fatigue,
but further studies are needed for the population in continuous use of




Isolated hypercholesterolemia and consumer of cardioprotective
foods
Renata A. Silva, Cristiane Kovacs, Carlos Daniel Magnoni
Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
Introduction: Diet is one of the changes in lifestyle recommended
for dyslipidemic patients, such as prevention of cardiovascular
events. Nutrition aims to stimulate the consumption of cardi-
oprotective food, the functional bioactive compounds: ﬁber, omega
3–6–9 and polyphenols. Objective: Reduction of plasma levels of
total cholesterol and fractions, in a hyperlipidemic patient without
medication. Methodology: hyperlipidemic patient received an orien-
tation cardioprotective foods (olive oil, yogurt, green tea, ﬂaxseed,
dark chocolate, ﬁsh, oats, soybeans and by-products, grape juice, nut,
avocado), with the recommendation for daily consumption to reduce
hypercholesterolemia, as the IV Guideline on Dyslipidemia. The
inclusion in the food routine was free choice. A food frequency
questionnaire of these foods and biochemical tests were obtained
before and after a follow-up three months. We selected a woman of
44 years without use of medications in primary prevention. Results:
Over the frequency of cardioprotective foods, the patient reported
using in the initial evaluation, only olive oil and ﬁsh, in the
recommendations. During treatment, the patient included, besides
the two already earlier: yogurt, linseed, dark chocolate, oats, whole
grape juice and oilseeds. Other foods (green tea, soybeans and by-
products and avocado) were included, but at a lower frequency than
the one suggested. The plasma levels decreased, in basal versus
90 days, 31.41% LDL-cholesterol, 8.19% HDL-cholesterol and 11.00%
triglyceride. The anthropometric measurements were reduced too:
weight (61.1 to 59.0 kg), body mass index (23.59 to 22.77 kg/m2)
and waist circumference (84.5 to 82.5 cm). Conclusion: A frequent
use of cardioprotective foods, can reduce the plasma levels of LDL-
cholesterol, with low interference in HDL-cholesterol.
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Introduction: The cyclo oxygenase (COX) enzymes are directly
involved in inﬂammation. Arachidonic acid is converted by COX to
prostaglandins (PG). PG participates in platelet activation, vasocon-
striction, gastrointestinal protection and bronchodilation. These
processes show an important association of COX-2 levels with major
adverse cardiovascular events. This effect suggests protection of
COX-2 in individuals who do not have it inhibited artiﬁcially. The
objective of this report is to demonstrate the association between
high COX-2 expression during the course of a patient with acute
myocardial infarction (AMI) undergoing coronarography. Case
report: A 54 year-old female patient, African descent, hypertensive
and former user of cocaine was admitted through the emergency
room with chest pain and anterior wall ischemia in the EKG. About
45 days before admission, she had been treated with angioplasty
with conventional stenting in the anterior descending artery. Serial
blood samples of each 6 h were made to assess the gene expression
of COX-2 and NF-kB activity. Our results showed a rise of COX-2 gene
expression and NF-kB after AMI diagnosis and coronarography
during time. Conclusion: Atherosclerosis is the major cause behind
major adverse cardiovascular events. The COX-2 has increased its
expression in symptomatic atherosclerotic plaques however plate
regions have fat cells that have no expression, suggesting that the
mechanism behind its regulation is more complex. Areas with higher
expression of COX-2 with great macrophage activity are subject to
instability and rupture, triggering the cascade of events culminating
in necrosis. In contrast, blocking the COX-2 action aggravates
ischemia because of its vasoconstrictor effect with consequent
increase in myocardial oxygen consumption. The balance between
the intensity of the inﬂammatory reaction and plaque instability
seems to be the scales between the concentration of PG E2 which is
pro instability of the plaque, and PG I2 a natural pro angiogenesis
stimulator
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